469 related articles for article (PubMed ID: 16447767)
1. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
Higuchi I
Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
[TBL] [Abstract][Full Text] [Related]
2. [Collagen VI-related muscle disorders].
Higuchi I
Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency.
Higashi K; Higuchi I; Niiyama T; Uchida Y; Shiraishi T; Hashiguchi A; Saito A; Horikiri T; Suehara M; Arimura K; Osame M
Muscle Nerve; 2006 Jan; 33(1):120-6. PubMed ID: 16258947
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease.
Usuki F; Yamashita A; Higuchi I; Ohnishi T; Shiraishi T; Osame M; Ohno S
Ann Neurol; 2004 May; 55(5):740-4. PubMed ID: 15122717
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease.
Hu J; Higuchi I; Shiraishi T; Suehara M; Niiyama T; Horikiri T; Uchida Y; Saito A; Osame M
Muscle Nerve; 2002 Nov; 26(5):696-701. PubMed ID: 12402292
[TBL] [Abstract][Full Text] [Related]
6. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
[TBL] [Abstract][Full Text] [Related]
7. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
[TBL] [Abstract][Full Text] [Related]
8. Frameshift mutation in the collagen VI gene causes Ullrich's disease.
Higuchi I; Shiraishi T; Hashiguchi T; Suehara M; Niiyama T; Nakagawa M; Arimura K; Maruyama I; Osame M
Ann Neurol; 2001 Aug; 50(2):261-5. PubMed ID: 11506412
[TBL] [Abstract][Full Text] [Related]
9. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
[TBL] [Abstract][Full Text] [Related]
10. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy.
Mercuri E; Lampe A; Allsop J; Knight R; Pane M; Kinali M; Bonnemann C; Flanigan K; Lapini I; Bushby K; Pepe G; Muntoni F
Neuromuscul Disord; 2005 Apr; 15(4):303-10. PubMed ID: 15792870
[TBL] [Abstract][Full Text] [Related]
11. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.
Jöbsis GJ; Keizers H; Vreijling JP; de Visser M; Speer MC; Wolterman RA; Baas F; Bolhuis PA
Nat Genet; 1996 Sep; 14(1):113-5. PubMed ID: 8782832
[TBL] [Abstract][Full Text] [Related]
12. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
[TBL] [Abstract][Full Text] [Related]
13. [Specific inhibition of nonsense-mediated mRNA decay has the potential to rescue the phenotype of muscular dystrophy].
Usuki F
Rinsho Shinkeigaku; 2006 Nov; 46(11):939-41. PubMed ID: 17432226
[TBL] [Abstract][Full Text] [Related]
14. Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency.
Higuchi I; Horikiri T; Niiyama T; Suehara M; Shiraishi T; Hu J; Uchida Y; Saito A; Nakagawa M; Arimura K; Osame M
Neuromuscul Disord; 2003 May; 13(4):310-6. PubMed ID: 12868500
[TBL] [Abstract][Full Text] [Related]
15. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
[TBL] [Abstract][Full Text] [Related]
16. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.
Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG
J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255
[TBL] [Abstract][Full Text] [Related]
17. Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.
Caria F; Cescon M; Gualandi F; Pichiecchio A; Rossi R; Rimessi P; Cotti Piccinelli S; Gallo Cassarino S; Gregorio I; Galvagni A; Ferlini A; Padovani A; Bonaldo P; Filosto M
Neuromuscul Disord; 2019 Sep; 29(9):657-663. PubMed ID: 31471117
[TBL] [Abstract][Full Text] [Related]
18. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease.
Kawahara G; Okada M; Morone N; Ibarra CA; Nonaka I; Noguchi S; Hayashi YK; Nishino I
Neurology; 2007 Sep; 69(10):1043-9. PubMed ID: 17785674
[TBL] [Abstract][Full Text] [Related]
19. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.
Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G
Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
